Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT06474533
Eligibility Criteria:
Inclusion Criteria:
* Presence or suspicion of intracranial neoplasm in two populations:
* Population 1: Participants after primary treatment (radiation therapy and/or surgery) with suspicion of recurrence on MRI.
* Three sub-populations will be considered:
* Recurrent metastatic lesions.
* Recurrent high-grade gliomas (Grades 3 and 4).
* Recurrent low-grade gliomas (Grade 2).
* Population 2: Participants prior to primary treatment with planned biopsy or surgical resection.
* Age \> 3 years.
Participants in other clinical trials will be eligible for this study including patients undergoing surgery guided by 5-aminolevulinic acid.
Exclusion Criteria:
* Participants with known incompatibility to PET or Computerized tomography (CT)/magnetic resonance imaging (MRI) scans.
* Participants unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator to be unsuitable for study participation.
* Sedation or anesthesia can be used for participants who cannot tolerate the exam.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Study:
NCT06474533
Study Brief:
Protocol Section:
NCT06474533